Literature DB >> 14601039

The neurobiology of bipolar disorder.

Gregory S Berns1, Charles B Nemeroff.   

Abstract

The neurobiology of bipolar disorder is reviewed. Bipolar disorder is associated with alterations in central nervous system (CNS) function from the level of large-scale brain circuits to intracellular signal transduction mechanisms. Because of the broad spectrum over which these abnormalities appear, the causative effects are most likely present in the lowest common denominator of all of these systems. Current evidence points to subtle alterations in signal transduction that reverberate downstream both intra- and extracellularly to produce the symptoms of bipolar disorder. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14601039     DOI: 10.1002/ajmg.c.20016

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  10 in total

Review 1.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

Review 2.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

3.  Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Authors:  Emily Moon; Brandi Rollins; Andrea Mesén; Adolfo Sequeira; Richard M Myers; Huda Akil; Stanley J Watson; Jack Barchas; Edward G Jones; Alan Schatzberg; William E Bunney; Lynn E DeLisi; William Byerley; Marquis P Vawter
Journal:  Schizophr Res       Date:  2011-07-13       Impact factor: 4.939

4.  Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice.

Authors:  Saiful Alom Siddique; Thangavel Tamilselvan; Manikkannan Vishnupriya; Elumalai Balamurugan
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

5.  Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.

Authors:  Anne M Cataldo; Donna L McPhie; Nicholas T Lange; Steven Punzell; Sarah Elmiligy; Nancy Z Ye; Michael P Froimowitz; Linda C Hassinger; Emily B Menesale; Laura W Sargent; David J Logan; Anne E Carpenter; Bruce M Cohen
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

Review 6.  A final common pathway for depression? Progress toward a general conceptual framework.

Authors:  Eric A Stone; Yan Lin; David Quartermain
Journal:  Neurosci Biobehav Rev       Date:  2007-10-10       Impact factor: 8.989

7.  Is subclinical anxiety an endophenotype for bipolar I patients? A study from a Costa Rican sample.

Authors:  Javier Contreras; Elizabeth Hare; Adriana Pacheco; Michael Escamilla; Henriette Raventos
Journal:  J Affect Disord       Date:  2009-09-04       Impact factor: 4.839

8.  Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.

Authors:  Richard Scott Jope
Journal:  Front Mol Neurosci       Date:  2011-08-09       Impact factor: 5.639

9.  Quantitative genetic analysis of anxiety trait in bipolar disorder.

Authors:  J Contreras; E Hare; G Chavarría; H Raventós
Journal:  J Affect Disord       Date:  2017-08-15       Impact factor: 6.533

10.  Does "crisis-induced intermittency" explain bipolar disorder dynamics?

Authors:  Fatemeh Hadaeghi; Mohammad R Hashemi Golpayegani; Keivan Moradi
Journal:  Front Comput Neurosci       Date:  2013-08-23       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.